收藏切换
Research Progress of Nanodelivery Systems for siRNA Drugs in Lung-targeted Therapy of Respiratory Diseases
收藏切换
Jiahui WANG, Fenghua GU*
Chinese Journal of Pharmaceuticals | 2026, 57(5) : 499 - 507
Less
收藏切换
Chinese Journal of Pharmaceuticals | 2026, 57(5): 499-507
• Perspective & Review •
Research Progress of Nanodelivery Systems for siRNA Drugs in Lung-targeted Therapy of Respiratory Diseases
Full
Jiahui WANG, Fenghua GU*
Affiliations
  • China State Institute of Pharmaceutical Industry, Shanghai 201203
Published: 2026-05-10 doi: 10.16522/j.cnki.cjph.2026.05.001
Outline
收藏切换

Small interfering RNA(siRNA) is a programmable gene-silencing therapeutic agent that can specifically downregulate the expression of pathogenic genes through the RNA interference mechanism, thereby exhibiting significant potential in precision therapy for respiratory diseases. In recent years, siRNA agents targeting key pathogenic genes in respiratory diseases have shown promising therapeutic efficacy in disease models such as lung cancer, asthma,COPD, and idiopathic pulmonary fibrosis. However, naked siRNA suffers from several limitations, including poor in vivo stability, high susceptibility to nuclease degradation, low transmembrane delivery efficiency, difficulty in penetrating the pulmonary mucus barrier, and inadequate endosomal escape capability, which severely hinder its clinical translation. To address these challenges, various nanoscale delivery systems, including lipid nanoparticles, polymeric nanoparticles, viral vectors, inorganic nanomaterials, and exosomes, have been developed for the efficient delivery of siRNA to pulmonary lesions. Centered on the “disease - siRNA target - delivery system” framework, this review systematically summarizes the research progress of representative siRNA-based nanoscale delivery systems for respiratory diseases. It critically examines how different nanocarriers influence siRNA delivery efficiency with respect to systemic circulation stability, pulmonary targeting, mucus penetration, cellular uptake, and endosomal escape. Furthermore, it outlines optimization strategies such as passive targeting, ligand modification, stimuli-responsiveness, and biomimetic modification, aiming to provide a reference for further research and clinical translation of siRNA therapeutics for lung-targeted treatment of respiratory diseases.

small interfering RNA  /  nanodelivery system  /  lung targeting  /  respiratory disease  /  gene silencing  /  research progress
王佳慧, 顾丰华. siRNA药物纳米递送系统在呼吸系统疾病肺靶向治疗中的研究进展. 中国医药工业杂志, 2026 , 57 (5) : 499 -507 . DOI: 10.16522/j.cnki.cjph.2026.05.001
Jiahui WANG, Fenghua GU. Research Progress of Nanodelivery Systems for siRNA Drugs in Lung-targeted Therapy of Respiratory Diseases[J]. Chinese Journal of Pharmaceuticals, 2026 , 57 (5) : 499 -507 . DOI: 10.16522/j.cnki.cjph.2026.05.001
Year 2026 volume 57 Issue 5
162
49
Cite this Article
BibTeX
Article Info
doi: 10.16522/j.cnki.cjph.2026.05.001
  • Receive Date:2025-07-09
  • Online Date:2026-11-05
  • Published:2026-05-10
Article Data
Affiliations
History
  • Received:2025-07-09
Affiliations
    China State Institute of Pharmaceutical Industry, Shanghai 201203
References
Share
https://castjournals.cast.org.cn/joweb/zgyygy/EN/10.16522/j.cnki.cjph.2026.05.001
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT